AZD3264 structure
|
Common Name | AZD3264 | ||
---|---|---|---|---|
CAS Number | 1609281-86-8 | Molecular Weight | 441.503 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 614.2±55.0 °C at 760 mmHg | |
Molecular Formula | C21H23N5O4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 325.2±31.5 °C |
Use of AZD3264AZD3264 is a selective IkB-kinase IKK2 inhibitor. |
Name | azd3264 |
---|---|
Synonym | More Synonyms |
Description | AZD3264 is a selective IkB-kinase IKK2 inhibitor. |
---|---|
Related Catalog | |
Target |
IKK2 |
In Vivo | AZD3264 is a selective IkB-kinase IKK2 inhibitor, which is currently in preclinical development for the potential treatment of chronic pulmonary obstructive disorder (COPD) and asthma[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 614.2±55.0 °C at 760 mmHg |
Molecular Formula | C21H23N5O4S |
Molecular Weight | 441.503 |
Flash Point | 325.2±31.5 °C |
Exact Mass | 441.147064 |
LogP | 2.08 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.653 |
Storage condition | -20℃ |
2-(Carbamoylamino)-5-{4-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[(3S)-3-pyrrolidinyloxy]phenyl}-3-thiophenecarboxamide |
3-Thiophenecarboxamide, 2-[(aminocarbonyl)amino]-5-[4-(3,5-dimethyl-4-isoxazolyl)-2-[(3S)-3-pyrrolidinyloxy]phenyl]- |